Central govt to review drug pricing in 10 nations to make medicines inexpensive in India

The target of the analysis is to grasp the drug pricing methodology adopted within the worldwide market masking a minimum of 10 nations, together with China, Sri Lanka, Bangladesh and america

Representational picture. Reuters

To make medication accessible and inexpensive in India, the Narendra Modi authorities is ready to kickstart a examine on drug pricing insurance policies of a minimum of 10 nations, together with China, Sri Lanka, Bangladesh and america, News18.com has realized. The division of prescription drugs (DoP) – underneath the union ministry of chemical compounds and fertilizers – has rolled out a young looking for a reputed firm that may conduct the examine on behalf of the federal government.

The target of the analysis is to grasp the drug pricing methodology adopted within the worldwide market masking a minimum of 10 nations. It additionally goals to grasp the teachings realized or the very best practices from numerous nations (or areas) when it comes to the supply and affordability of medication.

NPPA on the helm

In keeping with the request for proposal (RFP) doc labelled ‘Discover Inviting Tenders’, accessed by News18.com, drug pricing watchdog Nationwide Prescribed drugs Pricing Authority (NPPA) wishes to have interaction reputed corporations or analysis establishments for conducting a examine. NPPA is an arm of the DoP.

The title of the doc reads “To check the drug pricing insurance policies of various nations/ areas and classes realized from these nations/ areas when it comes to entry to drugs at inexpensive costs”.

The deadline to submit the proposal is February 21, the doc states, whereas shortlisted bidders can be known as for presentation on 1 March.

Research will contain secondary sources, prime 10 nations chosen

The federal government, based on the doc, plans to review regulatory coverage or framework on drug pricing of a minimum of 10 nations (or areas), to determine finest practices or classes realized. It additionally plans to review the operational implementation of the drug pricing insurance policies in several nations other than learning different coverage points that impression the supply and affordability of medication in these nations.

“The minimal ten nations/areas that ought to be coated are Sri Lanka, Bangladesh, China, EU, UK, Australia, USA, Brazil, South Africa, and Thailand,” the doc states.

The examine will primarily be based mostly on secondary sources of information and different info accessible in public area. It additionally entails interviews or focuses group discussions (FGDs) with international missions, related commerce and trade associations, drug exporters, international producers to elicit their suggestions or views.

In keeping with the 18-page RFP doc, the ultimate report after the number of the agency must be submitted in 4 months. “Moreover this, quarterly progress shall be submitted by the applicant until the ultimate submission of the report,” it says.

Learn all of the Newest InformationTrending InformationCricket InformationBollywood Information,
India Information and Leisure Information right here. Comply with us on Fb, Twitter and Instagram.

Writer

Originally posted 2022-01-15 09:53:30.


Posted

in

by